Please login to the form below

Not currently logged in
Email:
Password:

Editas Medicine

This page shows the latest Editas Medicine news and features for those working in and with pharma, biotech and healthcare.

Sangamo’s first gene-editing trial doesn’t convince investors

Sangamo’s first gene-editing trial doesn’t convince investors

Principal investigator Joseph Muenzer of the University of North Carolina (UNC) School of Medicine in Chapel Hill described those reductions are encouraging, saying: “We hope to understand the clinical relevance of ... But companies developing other

Latest news

  • Allergan builds on gene editing deal Allergan builds on gene editing deal

    disorder. Building on its existing deal with genome editing company Editas Medicine, Allergan will co-develop and co-commercialise EDIT-101 with the candidate’s original manufacturer, which is part of ... David Nicholson, chief research and development

  • Bayer forms JV with gene editing firm CRISPR Bayer forms JV with gene editing firm CRISPR

    CRISPR was formed by a team led by Emmanuelle Charpentier, who was awarded the Janssen Award for Biomedical Research last year - along with Jennifer Doudna of Editas Medicine - for the discovery

  • Vertex forges ties with gene editing firm CRISPR Therapeutics Vertex forges ties with gene editing firm CRISPR Therapeutics

    CRISPR Therapeutics was formed by a team led by Emmanuelle Charpentier, who was awarded the Janssen Award for Biomedical Research last year - along with Jennifer Doudna of Editas Medicine - for the ... Editas - backed by Google and Bill Gates - has yet

  • Altering genes on demand Altering genes on demand

    set up Editas Medicine.

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    Editas Medicine has entered a strategic R&D alliance where Allergan has exclusive access to Editas’s CRISPR genome-editing programmes in ocular health, as well as options to license up ... 100. Editas. Allergan. R&D alliance. LCA10 and up to four other

  • Deal Watch May 2016 Deal Watch May 2016

    This follows the $94m IPO of Editas Medicine in February this year.

  • Deal Watch October 2015 Deal Watch October 2015

    companies. Other biotechs exploiting the CRISPR/Cas-9 technology for the development of therapeutics include Editas Medicine, Intellia Therapeutics and Caribou Biosciences; both Novartis and AstraZeneca have already developed collaborations in

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Editas Medicine names James Mullen as chairman Editas Medicine names James Mullen as chairman

    Editas Medicine names James Mullen as chairman. He has previously served as CEO of Patheon. ... Genome editing company Editas Medicine has appointed James Mullen as chairman of the board of directors.

  • Editas Medicine adds to its board of directors Editas Medicine adds to its board of directors

    Editas Medicine adds to its board of directors. Jessica Hopfield will also serve on the genome editing firm's audit committee. ... She said: “I am honoured to join Editas Medicine’s board of directors. “

  • Editas Medicine adds to board of directors Editas Medicine adds to board of directors

    Editas Medicine adds to board of directors. Alnylam Pharmaceuticals’ Dr Akshay Vaishnaw joins. ... Cambridge, Massachusetts-based Editas Medicine has appointed Dr Akshay Vaishnaw to its board of directors.

More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics